LGALS3 and pulmonary fibrosis: Conversely, SSc-ILD patients showed a 6.08% annual reduction in lung volume (already low at baseline), lower CT densitometry values across slices, and an increase in galectin-3—suggestive of progressive pulmonary fibrosis rather than renal involvement.